» Articles » PMID: 25347745

Anti-angiogenic Pathway Associations of the 3p21.3 Mapped BLU Gene in Nasopharyngeal Carcinoma

Overview
Journal Oncogene
Date 2014 Oct 28
PMID 25347745
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Zinc-finger, MYND-type containing 10 (ZMYND10), or more commonly called BLU, expression is frequently downregulated in nasopharyngeal carcinoma (NPC) and many other tumors due to promoter hypermethylation. Functional evidence shows that the BLU gene inhibits tumor growth in animal assays, but the detailed molecular mechanism responsible for this is still not well understood. In current studies, we find that 93.5% of early-stage primary NPC tumors show downregulated BLU expression. Using a PCR array, overexpression of the BLU gene was correlated to the angiogenesis network in NPC cells. Moreover, expression changes of the MMP family, VEGF and TSP1, were often detected in different stages of NPC, suggesting the possibility that BLU may be directly involved in the microenvironment and anti-angiogenic activity in NPC development. Compared with vector-alone control cells, BLU stable transfectants, derived from poorly-differentiated NPC HONE1 cells, suppress VEGF165, VEGF189 and TSP1 expression at both the RNA and protein levels, and significantly reduce the secreted VEGF protein in these cells, reflecting an unknown regulatory mechanism mediated by the BLU gene in NPC. Cells expressing BLU inhibited cellular invasion, migration and tube formation. These in vitro results were further confirmed by in vivo tumor suppression and a matrigel plug angiogenesis assay in nude mice. Tube-forming ability was clearly inhibited, when the BLU gene is expressed in these cells. Up to 70-90% of injected tumor cells expressing increased exogenous BLU underwent cell death in animal assays. Overexpressed BLU only inhibited VEGF165 expression in differentiated squamous NPC HK1 cells, but also showed an anti-angiogenic effect in the animal assay, revealing a complicated mechanism regulating angiogenesis and the microenvironment in different NPC cell lines. Results of these studies indicate that alteration of BLU gene expression influences anti-angiogenesis pathways and is important for the development of NPC.

Citing Articles

Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis.

Wu L, Huang J, Trivedi P, Sun X, Yu H, He Z Discov Oncol. 2022; 13(1):139.

PMID: 36520265 PMC: 9755447. DOI: 10.1007/s12672-022-00597-9.


Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.

Ye M, Li L, Liu D, Wang Q, Zhang Y, Zhang J PeerJ. 2021; 9:e12276.

PMID: 34721975 PMC: 8530103. DOI: 10.7717/peerj.12276.


Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway.

Qin Z, Li Q, Yi H, Lu S, Huang W, Rong Z Front Oncol. 2020; 10:104.

PMID: 32117754 PMC: 7025553. DOI: 10.3389/fonc.2020.00104.


Tumor suppressor BLU exerts growth inhibition by blocking ERK signaling and disrupting cell cycle progression through RAS pathway interference.

Zhang X, Shao S, Zhou J, Li X, Zheng B, Huang Z Int J Clin Exp Pathol. 2020; 11(1):158-168.

PMID: 31938097 PMC: 6957978.


7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis.

Li H, Gao C, Liu L, Zhuang J, Yang J, Liu C Front Oncol. 2019; 9:1348.

PMID: 31850229 PMC: 6901675. DOI: 10.3389/fonc.2019.01348.


References
1.
Linderholm B, Lindh B, Tavelin B, Grankvist K, Henriksson R . p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer. 2000; 89(1):51-62. View

2.
Ghajar C, Peinado H, Mori H, Matei I, Evason K, Brazier H . The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013; 15(7):807-17. PMC: 3826912. DOI: 10.1038/ncb2767. View

3.
Kaur S, Martin-Manso G, Pendrak M, Garfield S, Isenberg J, Roberts D . Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem. 2010; 285(50):38923-32. PMC: 2998110. DOI: 10.1074/jbc.M110.172304. View

4.
Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, Hesson L . Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene. 2003; 22(10):1580-8. DOI: 10.1038/sj.onc.1206243. View

5.
Ancelin M, Buteau-Lozano H, Meduri G, Osborne-Pellegrin M, Sordello S, Plouet J . A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Proc Natl Acad Sci U S A. 2002; 99(9):6023-8. PMC: 122895. DOI: 10.1073/pnas.082110999. View